In this final episode of The Biotech Startups Podcast series, Jon Chee sits down with Mati Gill, CEO of AION Labs, to unpack where AI value is actually being created in biopharma—and what comes next. Mati lays out three pillars driving a post-hype phase of sustainable growth, explains why the industry is structurally conservative for good reasons, and shares how AION Labs is already preparing for the quantum computing wave before it arrives.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Excedr. Innehållet i podden är skapat av Excedr och inte av, eller tillsammans med, Poddtoppen.